vrijdag 24 september 2021

 Google Docs censors sharing by COVID-19 doctor linked to Trump

Dr. Vladimir Zelenko

LifeSiteNews has been permanently banned on YouTube. Click HERE to sign up to receive emails when we add to our video library.


2 June, 2021 (NewsBusters) – Google has opened a new front in the online censorship fight — restricting access to documents created in Google Docs. 

Google Docs restricted Dr. Vladimir Zelenko, the first doctor to advocate for alternative COVID-19 treatments, from sharing six different documents. Users received a terms of service note when the doctor tried to share the documents with them. “We're sorry. You can't access this item because it is in violation of our Terms of Service,” went the Google alert. It was unclear what rule was broken.

He wasn’t surprised by the restriction, noting, “I called out the globalist elite” for how they handled the pandemic. The six documents that Google is censoring include an op-ed he wrote and a letter he sent to New York Gov. Andrew Cuomo about the pandemic.

The restrictions appear to be geared toward Zelenko and not necessarily the content, which was shareable on other accounts. The documents discussed his policy of “early intervention” as a way of preventing hospitalizations, which he said resulted in an “84 percent reduction in hospitalizations” for COVID-19 patients. 

Zelenko is used to social media censorship. He’s been restricted by Facebook and YouTube and also had his Twitter account suspended. He added that Google search has also limited access to his own site, https://vladimirzelenkomd.com. A Google Incognito search lists the doctor’s site 39 or the fourth page of results. The search engine DuckDuckGo lists the site No. 1.

Correspondence from Dr Vladimir Zelenko on Treatment of 
COVID-19 in New York:

Dr. Vladimir (Zev) Zelenko

Board Certified Family Practitioner

501 Rt 208, Monroe, NY 10950

845-238-0000

 

March 23, 2020

 

To all medical professionals around the world:

 

My name is Dr. Zev Zelenko and I practice medicine in Monroe, NY. For the last 16 years, I have cared for approximately 75% of the adult population of Kiryas Joel, which is a very close knit community of approximately 35,000 people in which the infection spread rapidly and unchecked prior to the imposition of social distancing.

 

As of today my team has tested approximately 200 people from this community for Covid-19, and 65% of the results have been positive. If extrapolated to the entire community, that means more than 20,000 people are infected at the present time. Of this group, I estimate that there are 1500 patients who are in the high-risk category (i.e. >60, immunocompromised, comorbidities, etc).

 

Given the urgency of the situation, I developed the following treatment protocol in the pre-hospital setting and have seen only positive results:

 

1.  Any patient with shortness of breath regardless of age is treated.

2.  Any patient in the high-risk category even with just mild symptoms is treated.

3.  Young, healthy and low risk patients even with symptoms are not treated (unless their circumstances change and they fall into category 1 or 2).

 

My out-patient treatment regimen is as follows:

 

1.  Hydroxychloroquine 200mg twice a day for 5 days

2.  Azithromycin 500mg once a day for 5 days

3.  Zinc sulfate 220mg once a day for 5 days



The rationale for my treatment plan is as follows. I combined the data available from China and South Korea with the recent study published from France (sites available on request). We know that hydroxychloroquine helps Zinc enter the cell. We know that Zinc slows viral replication within the cell. Regarding the use of azithromycin, I postulate it prevents secondary bacterial infections. These three drugs are well known and usually well tolerated, hence the risk to the patient is low.

 

Since last Thursday, my team has treated approximately 350 patients in Kiryas Joel and another 150 patients in other areas of New York with the above regimen.

 

Of this group and the information provided to me by affiliated medical teams, we have had ZERO deaths, ZERO hospitalizations, and ZERO intubations. In addition, I have not heard of any negative side effects other than approximately 10% of patients with temporary nausea and diarrhea.

 

In sum, my urgent recommendation is to initiate treatment in the outpatient setting as soon as possible in accordance with the above. Based on my direct experience, it prevents acute respiratory distress syndrome (ARDS), prevents the need for hospitalization and saves lives.

 

With much respect,

 

Dr. Zev Zelenko

 

cc: President Donald J. Trump; Mr. Mark Meadows, Chief of Staff



Fundamentele principes

Behandel patiënten op basis van klinische verdenking zo snel mogelijk, bij voorkeur binnen de eerste 5 dagen van symptomen. Voer PCR-tests uit, maar wacht de behandeling niet af in afwachting van de resultaten.

Risicostratificatie van patiënten

  • Patiënt met laag risico - jonger dan 45 jaar, geen comorbiditeiten en klinisch stabiel
  • Hoogrisicopatiënt - Ouder dan 45 jaar, jonger dan 45 jaar met comorbiditeiten of klinisch instabiel

Behandelingsopties

Patiënten met een laag risico
  • Ondersteunende zorg met vocht, koortscontrole en rust
  • Elementair Zink 50 mg 1 keer per dag gedurende 7 dagen
  • Vitamine C 1000 mg 1 keer per dag gedurende 7 dagen
  • Vitamine D3 5000iu 1 keer per dag gedurende 7 dagen
Optionele vrij verkrijgbare opties
  • Quercetine 500 mg 2 keer per dag gedurende 7 dagen of
  • Epigallocatechin-gallaat (EGCG) 400 mg 1 keer per dag gedurende 7 dagen
Patiënten met matig/hoog risico
  • Elementair Zink 50-100 mg eenmaal daags gedurende 7 dagen
  • Vitamine C 1000 mg 1 keer per dag gedurende 7 dagen
  • Vitamine D3 10000iu eenmaal per dag gedurende 7 dagen of 50000iu eenmaal per dag gedurende 1-2 dagen
  • Azithromycine 500 mg 1 keer per dag gedurende 5 dagen of
  • Doxycycline 100 mg 2 keer per dag gedurende 7 dagen
  • Hydroxychloroquine (HCQ) 200 mg 2 keer per dag gedurende 5-7 dagen en/of
  • Ivermectine 0,4-0,5 mg/kg/dag gedurende 5-7 dagen Een of beide HCQ en IVM kunnen worden gebruikt, en als er slechts één is, kan het tweede middel worden toegevoegd na ongeveer 2 dagen behandeling als er nog geen duidelijk herstel is waargenomen enz. .
Behandelingsopties
  • Dexamethason 6-12 mg 1 keer per dag gedurende 7 dagen of
  • Prednison 20 mg tweemaal daags gedurende 7 dagen, indien nodig afbouwen
  • Budesonide 1 mg/2 cc oplossing via vernevelaar tweemaal per dag gedurende 7 dagen
  • Bloedverdunners (oa Lovenox, Eliquis, Xarelto, Pradaxa, Aspirine)
  • Colchicine 0,6 mg 2-3 keer per dag gedurende 5-7 dagen
  • Monoklonale antilichamen
  • Home IV vloeistoffen en zuurstof

PROBEER PATIENTEN BUITEN HET ZIEKENHUIS TE HOUDEN

Griezelig nieuws voor de COVID-gevaccineerden

 12/09/2024 Een nieuw, angstaanjagend syndroom kan iedereen treffen, ongeacht leeftijd, die de prik krijgt. Een nieuw syndroom, het ‘ Post-A...